C. Albo-López

Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products.

S. Bonanad Boix, M. Mingot-Castellano, J. E. Megías-Vericat, 2022, Thrombosis research.

Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study.

M. Tormo, M. Sanz, J. Pérez-Simón, 2021, Transplantation and cellular therapy.